Onsdag 28 Oktober | 17:16:21 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

NeoDynamics Q3 - No sales but important regulatory milestone

2022-11-21 07:51:00

Redeye lowers its fair value range for NeoDynamics following the continuous assessment of the company’s financial position and an increased WACC due to a higher risk-free rate. Net sales were, as expected, practically zero in the quarter, but with a US launch during Q1 2023 and commenced production in the EU, we believe next year entails improved growth opportunities.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.